TORONTO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Matador Technologies Inc. (“Matador” or the “Company”) (TSXV: MATA) announces that the Company has acquired an additional 3.46 bitcoin for CAD$500,000 (USD$344,257). The 3.46 bitcoin was acquired at an average price of USD$99,580 per bitcoin, inclusive of fees and expenses. This acquisition brings Matador’s Bitcoin holdings to approximately 68.14 bitcoin (and Bitcoin equivalents), reinforcing its long-term capital preservation strategy. The Company continues to ope ...

Oxford, UK – 5 February 2025: OXB (LSE: OXB), a quality and innovation-led cell and gene therapy CDMO, today announces the appointment of Jefferies International Limited ("Jefferies") as its Joint Corporate Broker and Joint Financial Adviser, to work alongside RBC Capital Markets, with immediate effect. -Ends- Enquiries: OXB: Sophia Bolhassan, Head of Investor Relations – T: +44 (0) 1865 509 737 / E: ir@oxb.com ICR Healthcare:T: +44 (0)20 3709 5700 / E: oxb@icrhealthcare.com Mary-Jane Elliott / Angela Gray ...

VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (the “Company” or “AGN Pharma”) (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF), a Canadian clinical stage pharmaceutical development company, is pleased to announce that its wholly owned subsidiary, Algernon NeuroScience (AGN Neuro), has appointed Validcare as the contract research organization (“CRO”) for the Company’s upcoming randomized, double-blind, placebo-controlled Phase 2a DMT study of 40 stroke patients in Eu ...

VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ascot Resources Ltd. (TSX: AOT; OTCQX: AOTVF) (“Ascot” or the “Company”) is providing an update on the progress of the Premier Gold Project following an initial review conducted by President and Chief Executive Officer Jim Currie and his management team. Due to the limited availability of trained labour, underground development has commenced later than expected, with slower advancement than anticipated. As a result, the previously outlined timel ...

NEW YORK, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Ethical Web AI (d/b/a Bubblr Inc.) (OTC: BBLR), a leader in ethical technology innovation, proudly announces the appointment of Tom Symonds as Chief Executive Officer. Tom has been at the forefront of innovative technology for 25 years. He is a recognized pioneer in the field of immersive technology for enterprise, having founded Immerse.io and acted as CEO prior to joining Ethical Web. He also comes with a unique blend of corporate experience developed during his ...

VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE NEWSWIRE) -- ValOre Metals Corp. (“ValOre”; TSX‐V: VO; OTCQB: KVLQF; Frankfurt: KEQ0) today provided an update on developments concerning Hatchet Uranium Corp. (“Hatchet”), in which ValOre currently holds an approximate 56.8% ownership interest. Hatchet entered into agreements (the “Transactions”) with Skyharbour Resources Ltd. (“Skyharbour”), (CLICK HERE for ValOre news release on November 4, 2024), whereby Hatchet could acquire an 80% interest in Skyharbou ...

TORONTO and HOUSTON, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company focused on the development of Superkines for the treatment of cancer, and inflammatory and autoimmune diseases, today announced that its management team will participate in two upcoming investor conferences in February 2025. The company will also host one-on-one meetings with investors during these events. Oppenheimer Annual Heal ...

TORONTO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Halcones Precious Metals Corp. (TSX – V: HPM) (the “Company” or “Halcones”) is pleased to announce results from the first field program completed by the Company at the Polaris gold project, Chile (“Polaris” or the “Project”). Halcones’ geologists recently initiated field work comprised of mapping and sampling in a portion of the Project area. The samples consisted of continuous 1m long chip samples to ensure representative sampling. Highlights: The Polaris Project ...

- Primary endpoint achieved by both DURAVYU doses (1.34mg and 2.7mg) with extended time to first supplemental injection versus aflibercept control – - DURAVYU 2.7mg demonstrated an early and sustained improvement in BCVA with a 24-week gain of +7.1 letters and anatomical improvement of 76 microns reduction in CST paired with reduction in treatment burden of two-thirds – Favorable safety profile continues with no DURAVYU-related ocular or systemic SAEs – – Phase 3 non-inferiority pivotal program initiation a ...

Multiple Spot Agreements Signed with Major Organizations S&P Global Platts Publishes Weekly Pricing Based on Plug Plant Production SLINGERLANDS, N.Y., Feb. 05, 2025 (GLOBE NEWSWIRE) -- In a significant move towards a more flexible and dynamic green hydrogen market, Plug Power Inc. (NASDAQ:PLUG), a global leader in comprehensive hydrogen solutions for the green hydrogen economy, has introduced the first-ever spot pricing program for liquid green hydrogen, marking a major step forward in the industry. Hydroge ...